Nexentis Technologies Inc.
- NITO
- NASDAQ
- Chemicals
- AI Drug Discovery
- Precision Oncology
- Mitochondrial/Metabolic Disease
$3.06
Today −15.93%Quote Jul 13, 2026, 07:57 PM UTC
−30.83%over the last month
Max drawdown −44.4%From 1-month high −30.8%3 months −60.3%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About Nexentis Technologies
Nexentis Technologies Inc. develops and operates an AI and data-driven computational biotech platform. It focuses on mitochondrial biology, precision oncology, and inflammatory metabolic diseases.
Sector
Basic materials
Industry
Chemicals
Exchange
NASDAQ
Employees
9
Founded
2009
Market value
$2.5M
Approximate share count
Floor
$2.60
15.0% below price
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about NITOPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free